BioNote, Inc. (KRX: 377740)
South Korea
· Delayed Price · Currency is KRW
4,675.00
+30.00 (0.65%)
Nov 19, 2024, 9:07 AM KST
BioNote Revenue
BioNote had revenue of 26.28B KRW in the quarter ending June 30, 2024, with 3.40% growth. This brings the company's revenue in the last twelve months to 95.08B, down -27.96% year-over-year. In the year 2023, BioNote had annual revenue of 90.08B, down -81.22%.
Revenue (ttm)
95.08B
Revenue Growth
-27.96%
P/S Ratio
4.99
Revenue / Employee
319.06M
Employees
n/a
Market Cap
474.05B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 90.08B | -389.58B | -81.22% |
Dec 31, 2022 | 479.66B | -142.70B | -22.93% |
Dec 31, 2021 | 622.36B | -9.15B | -1.45% |
Dec 31, 2020 | 631.50B | 591.46B | 1,476.89% |
Dec 31, 2019 | 40.05B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition